Citigroup Inc Abb Vie Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Citigroup Inc holds 2,068,414 shares of ABBV stock, worth $372 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

2,068,414

Previous 2,371,557 12.78%

Holding current value

$372 Million

Previous $407 Million 0.42%

% of portfolio

0.24%

Previous 0.27%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $49.7 Million - $60.4 Million	-303,143 Reduced 12.78%	2,068,414 $408 Million
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $42.9 Million - $50.2 Million	277,449 Added 13.25%	2,371,557 $407 Million
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $32.9 Million - $37.5 Million	-205,907 Reduced 8.95%	2,094,108 $381 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $86 Million - $96.8 Million	-624,646 Reduced 21.36%	2,300,015 $356 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $59.2 Million - $68.6 Million	-443,329 Reduced 13.16%	2,924,661 $436 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $126 Million - $157 Million	951,771 Added 39.39%	3,367,990 $454 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $110 Million - $126 Million	-758,551 Reduced 23.89%	2,416,219 $385 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $55.2 Million - $66.2 Million	398,836 Added 14.37%	3,174,770 $513 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $19 Million - $21.8 Million	141,461 Added 5.37%	2,775,934 $373 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $9.51 Million - $12.1 Million	69,093 Added 2.69%	2,634,473 $403 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $15.6 Million - $19.3 Million	118,156 Added 4.83%	2,565,380 $416 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $30.2 Million - $38.2 Million	-281,373 Reduced 10.31%	2,447,224 $331 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $290 Million - $330 Million	2,728,597 New	2,728,597 $294 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account